Concepedia

Jianliang Shi

JS

11

Publications

208

Citations

11

H-Index

2007

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Jianliang Shi is an author at Bristol-Myers Squibb (United States) specializing in biochemistry, drug discovery, and medicinal chemistry.

Top concepts

Publications per year

2007–2023

11

Publications

11

Development of New Benzenesulfonamides As Potent and Selective Na<sub>v</sub>1.7 Inhibitors for the Treatment of Pain

Yong‐Jin Wu, Jason Guernon, Jianliang Shi et al. · Journal of Medicinal Chemistry · 2017 · 36 citations · Full text

Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents

Yong‐Jin Wu, Jason Guernon, Fukang Yang et al. · ACS Medicinal Chemistry Letters · 2016 · 30 citations · Full text

, , +26

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

Kenneth M. Boy, Jason Guernon, Dmitry Zuev et al. · ACS Medicinal Chemistry Letters · 2019 · 22 citations · Full text

Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE)

Kenneth M. Boy, Jason Guernon, Jianliang Shi et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 20 citations · Full text

, , +11

Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic Optimization

Louis Chupak, Michael Wichroski, Xiaofan Zheng et al. · ACS Medicinal Chemistry Letters · 2023 · 18 citations · Full text

Rows per page

1–5 of 11